The year 2010, the fifty-fifth year of the journal, has been very successful for the Indian Journal of Dermatology (IJD). We have been able to sustain the quality of the journal and strengthen our position further, after getting re-indexed in 2009. We had a record submission of 475 articles of which 16 were basic research and 77 original articles.

The policy of the journal is to invite Review and CME articles from academicians who have worked and contributed significantly in a particular field. However, we have been overwhelmed by the growing number of review articles, of good quality, being uploaded to the IJD website by various contributors. The spontaneous and enthusiastic response of our colleagues has encouraged us a lot in our efforts to make the journal better and richer in its content.

The acceptance rate for the journal articles has risen to 22% in 2010, from 6% in 2009, suggesting that we have been getting much better quality articles after getting indexed in PubMed.

To accommodate the increasing number of articles, we have decided to publish six issues in a year (bimonthly). This will be done for the first time in the 55-year history of IJD. We have worked very hard to shorten the duration of publication of the submitted articles to our system. Currently it takes approximately four to six months for an original article and nine to twelve months for a case report. Corresponding figures for the same had been six to eight months and twelve to eighteen months, respectively, over the last couple of years. Our effort is on, to shorten the period further.

Our newly introduced section, 'IJD Symposium' has been much appreciated by the readers. In the year 2010, we had published three excellent symposiums, 'Dengue and Chikungunya fever', 'Psoriasis,' and 'Chemical Leukoderma'. Some of the most eminent world authorities have contributed to the IJD Symposium.

Another important achievement of the journal, in 2009, was its worldwide popularity. Several articles from the IJD had featured regularly in the MDLinx site, which is supposed to be the most read site by US physicians. Some of the articles have even been placed at the top position. This is a phenomenal event, as hardly any Indian journal in any speciality has been found to feature in the site as frequently as IJD. The strength of IJD has been its rich content. We have regularly published 'Basic Reseach' articles over the last five years and we have also published a good number of original articles on various important issues.

In last one year, with the help of Medknow, we could add several innovative and futuristic features to our system, for example, E-Book desktop, Quick response code, Table of Contents (TOC) and search pages, Sword repository tool, mobile optimized sites, and monthly citation alerts, to name a few.

I am privileged to thank my two most able colleagues, both executive editors, Koushik Lahiri and Saumya Panda, for their tireless efforts and dedicated contributions. I am pleased to inform you that from 2012, there will be a change in guard and our beloved Koushik will take over as the Editor of IJD. I take this opportunity to thank Tapas Kayal, my assistant, for the smooth execution of the job allocated to him. I also thank my hard-working editorial team members, the committed editorial and editorial advisory board members, sincere reviewers, erudite contributors, and above all, our selfless unbiased readers.

I take this opportunity to thank all the esteemed executive body members of the Indian Association of Dermatologists, Venereologists, and Leprologists, West Bengal branch, for their support and cooperation during my tenure over the last four years. I must acknowledge and thank Dr. D K Sahu of Medknow Publications for his help, support, and guidance to get the journal indexed. His publishing house has not only been the publisher for the journal, but has also given very important and useful inputs with regard to improving the quality of the journal.

A journal can never run smoothly without funding from the pharmaceutical industry. I hereby thank Galderma India Pvt. Ltd., Fulford India Ltd., Glenmark Pharmaceuticals, Palsons Drugs and Chemical Industries, Janssen -- Cilag Pharmaceuticals, Neutrogena Pharma, UAS Pharma, Wyeth -- Pfizer, Sebapharma, GSK Derma, CIPLA, Talent India, and Curatio Health Care, who have supplied the necessary oxygen for the journal\'s survival.

Indian Journal of Dermatology, with all of your active support, cooperation, contribution, and blessing, has been growing very fast to reach the horizon of science where, "tireless striving stretches its arms towards perfection...".

I, on behalf of 'Team IJD', sincerely thank all of you for your kind patronage of IJD and hope that you will continue to do the same in the days to come. I wish all of you a very happy and prosperous 2011.
